291 related articles for article (PubMed ID: 35247927)
1. Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy.
Li J; Smalley I; Chen Z; Wu JY; Phadke MS; Teer JK; Nguyen T; Karreth FA; Koomen JM; Sarnaik AA; Zager JS; Khushalani NI; Tarhini AA; Sondak VK; Rodriguez PC; Messina JL; Chen YA; Smalley KSM
Clin Cancer Res; 2022 May; 28(10):2131-2146. PubMed ID: 35247927
[TBL] [Abstract][Full Text] [Related]
2. Clinicoprognostic characteristics of cutaneous metastatic melanoma: a retrospective comparative study between acral and nonacral melanoma.
Kang HJ; Choi ME; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
Int J Dermatol; 2020 Oct; 59(10):1249-1257. PubMed ID: 32720336
[TBL] [Abstract][Full Text] [Related]
3. Metastatic acral melanoma treatment outcomes: a systematic review and meta-analysis.
Cho KK; Cust AE; Foo YM; Long GV; Menzies AM; Eslick GD
Melanoma Res; 2021 Oct; 31(5):482-486. PubMed ID: 34433196
[TBL] [Abstract][Full Text] [Related]
4. Acral melanoma: new insights into the immune and genomic landscape.
Carvalho LAD; Aguiar FC; Smalley KSM; Possik PA
Neoplasia; 2023 Dec; 46():100947. PubMed ID: 37913653
[TBL] [Abstract][Full Text] [Related]
5. Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal Metastases.
Smalley I; Chen Z; Phadke M; Li J; Yu X; Wyatt C; Evernden B; Messina JL; Sarnaik A; Sondak VK; Zhang C; Law V; Tran N; Etame A; Macaulay RJB; Eroglu Z; Forsyth PA; Rodriguez PC; Chen YA; Smalley KSM
Clin Cancer Res; 2021 Jul; 27(14):4109-4125. PubMed ID: 34035069
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis.
Kuk D; Shoushtari AN; Barker CA; Panageas KS; Munhoz RR; Momtaz P; Ariyan CE; Brady MS; Coit DG; Bogatch K; Callahan MK; Wolchok JD; Carvajal RD; Postow MA
Oncologist; 2016 Jul; 21(7):848-54. PubMed ID: 27286787
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy Options for Acral Melanoma, A fast-growing but Neglected Malignancy.
Gajón JA; Juarez-Flores A; De León Rodríguez SG; Aguilar Flores C; Mantilla A; Fuentes-Pananá EM; Bonifaz LC
Arch Med Res; 2022 Dec; 53(8):794-806. PubMed ID: 36460547
[TBL] [Abstract][Full Text] [Related]
8. Acral melanoma: clinical advances and hope for the future.
Perez MC; Messina JL; Karapetyan L; Neves RI; Sondak VK
Clin Adv Hematol Oncol; 2023 Aug; 21(8):400-409. PubMed ID: 37530614
[TBL] [Abstract][Full Text] [Related]
9. Targeted Genomic Profiling of Acral Melanoma.
Yeh I; Jorgenson E; Shen L; Xu M; North JP; Shain AH; Reuss D; Wu H; Robinson WA; Olshen A; von Deimling A; Kwok PY; Bastian BC; Asgari MM
J Natl Cancer Inst; 2019 Oct; 111(10):1068-1077. PubMed ID: 30657954
[TBL] [Abstract][Full Text] [Related]
10. Mapping the single-cell landscape of acral melanoma and analysis of the molecular regulatory network of the tumor microenvironments.
He Z; Xin Z; Yang Q; Wang C; Li M; Rao W; Du Z; Bai J; Guo Z; Ruan X; Zhang Z; Fang X; Zhao H
Elife; 2022 Jul; 11():. PubMed ID: 35894206
[TBL] [Abstract][Full Text] [Related]
11. Acral Melanoma Is Infiltrated with cDC1s and Functional Exhausted CD8 T Cells Similar to the Cutaneous Melanoma of Sun-Exposed Skin.
De Leon-Rodríguez SG; Aguilar-Flores C; Gajón JA; Mantilla A; Gerson-Cwilich R; Martínez-Herrera JF; Rodríguez-Soto BE; Gutiérrez-Quiroz CT; Pérez-Koldenkova V; Muñoz-Cruz S; Bonifaz LC; Fuentes-Pananá EM
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902214
[TBL] [Abstract][Full Text] [Related]
12. Translational pathology, genomics and the development of systemic therapies for acral melanoma.
Chen YA; Teer JK; Eroglu Z; Wu JY; Koomen JM; Karreth FA; Messina JL; Smalley KSM
Semin Cancer Biol; 2020 Apr; 61():149-157. PubMed ID: 31689494
[TBL] [Abstract][Full Text] [Related]
13. Unexpected UVR and non-UVR mutation burden in some acral and cutaneous melanomas.
Rawson RV; Johansson PA; Hayward NK; Waddell N; Patch AM; Lo S; Pearson JV; Thompson JF; Mann GJ; Scolyer RA; Wilmott JS
Lab Invest; 2017 Feb; 97(2):130-145. PubMed ID: 28067894
[TBL] [Abstract][Full Text] [Related]
14. The pharmacotherapeutic management of nail unit and acral melanomas.
Falotico JM; Lipner SR
Expert Opin Pharmacother; 2022 Aug; 23(11):1273-1289. PubMed ID: 35702037
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the treatment-naive immune microenvironment in melanoma with
Wang M; Zadeh S; Pizzolla A; Thia K; Gyorki DE; McArthur GA; Scolyer RA; Long G; Wilmott JS; Andrews MC; Au-Yeung G; Weppler A; Sandhu S; Trapani JA; Davis MJ; Neeson PJ
J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35383113
[TBL] [Abstract][Full Text] [Related]
16. Clinical Activity of Ipilimumab in Acral Melanoma: A Retrospective Review.
Johnson DB; Peng C; Abramson RG; Ye F; Zhao S; Wolchok JD; Sosman JA; Carvajal RD; Ariyan CE
Oncologist; 2015 Jun; 20(6):648-52. PubMed ID: 25964307
[TBL] [Abstract][Full Text] [Related]
17. Management of Acral and Mucosal Melanoma: Medical Oncology Perspective.
Jung S; Johnson DB
Oncologist; 2022 Aug; 27(8):703-710. PubMed ID: 35640549
[TBL] [Abstract][Full Text] [Related]
18. Clinical Features and Outcomes of Black Patients With Melanoma.
Wix SN; Brown AB; Heberton M; Adamson AS; Gill JG
JAMA Dermatol; 2024 Mar; 160(3):328-333. PubMed ID: 38265787
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions.
Mao L; Qi Z; Zhang L; Guo J; Si L
Front Immunol; 2021; 12():680407. PubMed ID: 34149718
[TBL] [Abstract][Full Text] [Related]
20. Different progression pattern between acral and nonacral melanoma: A retrospective, comparative, clinicoprognostic study of 492 cases of primary cutaneous melanoma according to tumor site.
Jung JM; Jung CJ; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
Indian J Dermatol Venereol Leprol; 2021 [SEASON]; 87(4):498-508. PubMed ID: 33871216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]